The Washington Post Finally Reports What Frontline Doctors

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
231
The Washington Post Finally Reports What Frontline Doctors Have Warned About All Along: COVID Vaccine Can ‘Change The Timing Of The Menstrual Cycle’
September 28, 2022

Medical experts and frontline doctors who urged the public to refrain from getting covid vaccinated were ostracized and censored by the corporate press. Claims that the so-called “vaccines,” which provide no inoculation against transmission of covid, cause infertility were deemed a far-fetched conspiracy theory by the establishment.

Now, the same entities that promoted the globalist “get vaccinated” agenda are beginning to report the truth about the effects of the experimental gene modification shots.

A new report published by the Washington Post cites a study confirming covid injections negatively disrupt women’s menstrual cycles.

“Women said covid shots affect periods. A new study shows they’re right,” the article published by WaPo on Tuesday warns.

The far-left publication references a study published in on Tuesday by the National Institute of Health in the British Medical Journal. The study examined the menstrual cycles of women from around the world who used Natural Cycles, a popular period-tracking app. Amon participants, 14,936 women were vaccinated and 4,686 were not.

“Because app users tracked their menstrual cycles each month, the researchers were able to analyze three menstrual cycles before vaccination and at least one cycle after, and compare them with four menstrual cycles in the unvaccinated group,” the Washington Post notes.

According to the study, vaccinated women got their periods 0.71 days late after receiving one dose of mRNA-modifying technology, while women who received two “vaccines” within one menstrual cycle experienced “greater disruptions” The average double jabbed woman saw their cycle length increase by four days, while thirteen percent of those who received two shots experienced an eight-day delay or more.

“People have expressed frustration that public health officials didn’t warn them about the possible side effect or do more research before rolling out the vaccines,” WaPo reports.

The study fails to address the effects covid shots have on non-binary individuals, the publication warns.

“The study also didn’t answer all of the questions raised by people about vaccines and periods, including how the shots affect trans men and nonbinary individuals. Ever since the vaccines were rolled out, many people on social media have complained of longer, heavier and more-painful periods after getting vaccinated. This study did not look at the heaviness of periods or other side effects such as cramps.”

WaPo cites a second survey that examines the vaccine’s effects on the menstrual cycle of 160,000 participants, “including transgender and postmenopausal people.”

The survey found “that thousands of reported heavier bleeding than usual or breakthrough bleeding,” WaPo reports.

The heavy bleeding is especially problematic for transgender men, Tulane University assistant professor Katharine Lee told the outlet.

“The information is important to help trans men plan for additional support if menstruating causes gender dysphoria, and also to help people make decisions about stocking up on tampons and pads,” Lee explained.

One woman told WaPo that she “hadn’t had her period for over three years before she got her first Pfizer shot in February. The next day at work, she got her period.”

“It wasn’t that the vaccine moved my period early or late — it produced one,” said Lorena Grundy, 27, said. “I think it’s good to validate that we should listen to women about their own bodies.

“I’m still glad I got vaccinated, but I do think maybe this shows that it’s a symptom we should be preparing people for so they’re not alarmed by it.”

More from WaPo:

Olivia Rodriguez, 26, said she doesn’t plan to get her booster shot because she had such a bad experience after her second Moderna shot in March 2021. Despite just having finished her period, she started another within a few days of getting the shot. It lasted 10 days with heavier bleeding, she said, instead of the normal four or five days she was used to. She also experienced more-painful cramps.

Initially, she panicked, but soon found stories online of other women who had gone through similar situations. It was reassuring, she said, but she still is wary of getting another shot.

Rodriguez, who is a member of the Osage Nation, said medical researchers need to earn the trust of the Indigenous and people of color by providing more information upfront about side effects.

“I never really got an explanation of why or what happened,” she said.

The Washington Post’s expose of covid vaccine effects demonstrates the extent corporate press has obediently assisted big government’s depopulation effort by withholding the fact from the American public.

WaPo smears and libels frontline doctors and independent publications who reported on against the effects of the covid shots throughout the bioattack.

Dr. Robert Malone, who developed mRNA technology and has repeatedly warned against the use of the experimental shots has “bolstered a movement of misinformation,” The Washington Post warned in January.

The Gateway Pundit, which regularly reports on the detrimental effects of the jabs on the menstrual cycle and the reproductive system, is a “conspiracy-hawking site,” claims WaPo.

After Joe Rogan interviewed renowned epidemiologist, Dr. Peter McCullough, WaPo sounded the alarm in an article titled, “The coronavirus misinformation on Joe Rogan’s show, explained.”

Meanwhile, McCullough thoroughly explains exactly why women are experiencing delays in their menstrual cycle after getting vaccinated.

https://www.thegatewaypundit.com/2022/09/wash...2022-09-28
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ROKAE Hits 10,000 Delivery Mark for Robotic Arms

Updated Category News Views 132

ROKAE's Big 10K: A Milestone Worth Noting Alright, if you've been around the block as long as I have, you know the robotics game isn't just about making cool gadgets—it's about hitting those serious deployment numbers. ROKAE Robotics just rolled its 10,000th humanoid force-controlled arm off the line in Shandong, and this ain't just another notch on their belt. This...

Continue Reading
Shenzhen Hosts FDI Moot: A Key Milestone for Arbitration

Updated Category News Views 69

Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 73

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
Elbit Systems Lands $200M APAC ISTAR Contracts

Updated Category News Views 38

Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 222

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 56

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
E-Filing: Why Ditching IRS Paper Forms Matters Now

Updated Category News Views 50

Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...

Continue Reading

Top 5 Most Recently Viewed Articles

Shannon McGhee to Lead SEED SPOT as New CEO Driving Impact

Updated Category News Views 189

Shannon McGhee Takes the Helm at SEED SPOT SEED SPOT, a national social impact incubator focused on uplifting purpose-driven entrepreneurs, is excited to announce the appointment of Shannon McGhee as its new Chief Executive Officer. This leadership change marks a significant milestone for the organization as it steps towards its next chapter of growth. McGhee's Rich...

Continue Reading
Navigating the Lawsuit: Monolithic Power Systems Investors May Claim

Updated Category News Views 136

Investment Opportunity: The Monolithic Power Systems Lawsuit Investors in Monolithic Power Systems, Inc. (NASDAQ: MPWR) have a unique chance to engage in a securities fraud lawsuit that may lead to financial compensation. The lawsuit targets those who acquired common stock during a specified timeframe, raising awareness about the implications of their investments....

Continue Reading
Taiwan's AI Leap: Boosting Embryo Success Rates 24%

Updated Category News Views 9

Breaking New Ground in Fertility Treatment When it comes to fertility treatment, there are countless hopes tied up in embryonic success rates, especially when biology throws a fit. That's where Taiwan shines right now — introducing an AI-powered twist to the old embryo selection method. With the boom in infertility rates hitting one in six folks globally, here comes a...

Continue Reading
Hasbro's Strategy to Engage Adult Consumers in Toy Market

Updated Category News Views 684

Hasbro's Innovative Shift Towards the Adult Toy Market Toy manufacturer Hasbro Inc. (NASDAQ: HAS) is making a noteworthy pivot to target a burgeoning market, focusing on adults and teens, often labeled as 'kidults.' This growing consumer segment is contributing significantly to toy-related expenditures, leading many to invest substantial amounts in collectibles and...

Continue Reading
BMO Financial Group Announces Dividend Increase for Shareholders

Updated Category News Views 149

Overview of BMO's Recent Dividend Announcement Bank of Montreal (TSX:BMO) recently revealed its decision to enhance the quarterly dividend on its common shares. This increase of 4 cents represents a growth of 3 percent from the previous quarter and a notable 5 percent from the same period last year. This strategic move is pleasing for shareholders, reflecting the...

Continue Reading